|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-08S1
|
$66,889
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-08
|
$373,347
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Characterization of the gamma HV68 v-cyclin
|
2R01CA087650-06A2
|
$316,022
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S1
|
$103,800
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S3
|
$237,500
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-34
|
$9,881,120
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Molecular Basis of KSHV Pathogenesis
|
5R01CA082057-09
|
$338,914
|
JUNG, JAE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Cell growth deregulation by KSHV protein.
|
5R01CA106156-04
|
$315,086
|
JUNG, JAE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
KSHV RTA: more than viral replication
|
5R01CA115284-03
|
$316,480
|
JUNG, JAE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
2R01CA073585-11A2
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of KSHV in AIDS Malignancies
|
5P01CA113239-02
|
$1,106,966
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
HHV-8 vGPCR Signaling in Virus Biology
|
1R21CA119887-01A1
|
$163,750
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-08
|
$348,813
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of Chemokine Receptor ORF74 in Angioproliferation
|
5R01CA109259-04
|
$329,470
|
LIRA, SERGIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
Engels
|
DCEG (NCI)
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,395,646
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Lymphoma Disease Discovery and Defintion
|
Z01 SC 000550
|
$882,960
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
|
Z01 BC 006174
|
$233,343
|
Marquez, Victor
|
CCR (NCI)
|
|
Epidemiology and Natural History of Cancer-Associated Viruses
|
Z01 CP010176
|
$1,973,263
|
Mbulaiteye
|
DCEG (NCI)
|
|
Epidemiology of Oncogenic Viruses
|
Z01 CP005782
|
$225,419
|
O'Brien
|
DCEG (NCI)
|
|
KSHV and other oncogenic viruses
|
Z01 CP010151
|
$327,976
|
Whitby
|
DCEG (NCI)
|
|
Identification of Candidate Gene Polymorphisms Associated with Infectious Disease
|
Z01 BC 010297
|
$361,857
|
Winkler, Cheryl Ann
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies
|
Z01 SC 006737
|
$1,286,719
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
5P30CA016087-27
|
$2,563,433
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-32
|
$3,716,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Role of Oxidants & Angiogenesis in Kaposi's Sarcoma
|
5R01CA095901-05
|
$285,126
|
Mallery, Susan
|
OHIO STATE UNIVERSITY
|
|
OHSU Cancer Institute
|
3P30CA069533-11S1
|
$67,584
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Cancer Institute
|
5P30CA069533-11
|
$1,133,755
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanisms of KSHV-Induced Cellular Transformation
|
5R01CA099906-04
|
$234,807
|
MOSES, ASHLEE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
28th International Herpesvirus Workshop,
|
5R13CA102553-05
|
$14,223
|
NELSON, JAY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
10th International KSHV and Related Agents Workshop
|
1R13CA128447-01
|
$5,000
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Biology of HHV-8 interactions with host cells
|
5R01CA099925-04
|
$295,455
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Immune evasion by KSHV
|
5R01CA108447-04
|
$232,763
|
COSCOY, LAURENT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Cancer Center Support Grant - P30
|
3P30CA093373-06S1
|
$114,000
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Cancer Center Support Grant - P30
|
5P30CA093373-06
|
$2,829,691
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
K-bZIP and Transcriptional Regulation of KSHV
|
5R01CA111185-04
|
$223,860
|
Kung, Hsing-Jien
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S2
|
$108,416
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S3
|
$113,053
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
5P30CA016042-33
|
$4,541,766
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Immune Dysfunction and AIDS-associated B Cell Lymphoma
|
3R01CA057152-13S1
|
$163,086
|
MARTINEZ-MAZA, OTONIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|